Total and cellular MP levels per µl of plasma at follow-up/discharge (7 days after admission:

<p><i>A</i>) versus levels on admission. (<b>A</b>): T-MP:annexin V⁺; (<b>B</b>): P-MP:CD41⁺; (<b>C</b>): E-MP:CD105⁺; (<b>D</b>): R-MP:CD235a⁺; (<b>E</b>): M-MP:CD11b⁺; (<b>F</b>): L-MP:CD3⁺. Dot plot representations showing how in most of the cases, MP levels decreases in patients with CM at discharge (<i>D</i>). Control group is represented to show that patient levels are returning to control levels. C: Controls; SA: severe malaria anemia patients on admission; CM: cerebral malaria patients on admission; CM+SA: patients with the combine symptoms of CM and SMA on admission; SA(D): severe malaria anemia patients at discharge; CM(D): cerebral malaria patients at discharge; CM+SA(D): patients with the combine symptoms of CM and SMA at discharge; MP levels are given in MP/µl of plasma. The values of the deceased patients are presented as black stars on <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0013415#pone-0013415-g003" target="_blank">Figure 3</a>. *: p<0.05, **: p<0.001, ***: p<0.0001.